SOLVENTUM CORPORATION Operating Cash Flow
SOLVENTUM CORPORATION (SOLV) reported Operating Cash Flow of $38.00 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2026-08-05
- SOLVENTUM CORPORATION net cash provided by (used in) operating activities for the quarter ending 2026-06-30 was $227.00M, a 34.32% increase year-over-year.
- SOLVENTUM CORPORATION net cash provided by (used in) operating activities for the quarter ending 2026-03-31 was -$189.00M, a 751.72% decline year-over-year.
- SOLVENTUM CORPORATION net cash provided by (used in) operating activities for the quarter ending 2025-12-31 was $95.00M, a 56.62% decline year-over-year.
- SOLVENTUM CORPORATION net cash provided by (used in) operating activities for the quarter ending 2025-09-30 was $76.00M, a 55.03% decline year-over-year.
- SOLVENTUM CORPORATION net cash provided by (used in) operating activities for fiscal 2025 was $369.00M, a 68.86% decline from fiscal 2024.
- SOLVENTUM CORPORATION net cash provided by (used in) operating activities for fiscal 2024 was $1.19B, a 38.12% decline from fiscal 2023.
- SOLVENTUM CORPORATION net cash provided by (used in) operating activities for fiscal 2023 was $1.92B, a 14.06% increase from fiscal 2022.
- SOLVENTUM CORPORATION net cash provided by (used in) operating activities for fiscal 2022 was $1.68B.
| Period end | Net Cash Provided by (Used in) Operating Activities 3 month | Net Cash Provided by (Used in) Operating Activities 6 month | Net Cash Provided by (Used in) Operating Activities 9 month | Net Cash Provided by (Used in) Operating Activities 12 month |
|---|---|---|---|---|
| 2026-06-30 | $227.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $38.00M 10-Q · filed 2026-08-05 | $133.00M derived: sum of 3 quarters · filed 2026-08-05 | $209.00M derived: sum of 4 quarters · filed 2026-08-05 |
| 2026-03-31 | -$189.00M 10-Q · filed 2026-05-05 | -$94.00M derived: sum of 2 quarters · filed 2026-05-05 | -$18.00M derived: sum of 3 quarters · filed 2026-05-05 | $151.00M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-12-31 | $95.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $171.00M derived: sum of 2 quarters · filed 2026-02-27 | $340.00M derived: sum of 3 quarters · filed 2026-08-05 | $369.00M 10-K · filed 2026-02-27 |
| 2025-09-30 | $76.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $245.00M derived: sum of 2 quarters · filed 2026-08-05 | $274.00M 10-Q · filed 2025-11-06 | $493.00M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-06-30 | $169.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $198.00M 10-Q · filed 2026-08-05 | $417.00M derived: sum of 3 quarters · filed 2026-08-05 | $586.00M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-03-31 | $29.00M 10-Q · filed 2026-05-05 | $248.00M derived: sum of 2 quarters · filed 2026-05-05 | $417.00M derived: sum of 3 quarters · filed 2026-05-05 | $772.00M derived: sum of 4 quarters · filed 2026-05-05 |
| 2024-12-31 | $219.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $388.00M derived: sum of 2 quarters · filed 2026-02-27 | $743.00M derived: sum of 3 quarters · filed 2026-02-27 | $1.19B 10-K · filed 2026-02-27 |
| 2024-09-30 | $169.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $524.00M derived: sum of 2 quarters · filed 2025-11-06 | $966.00M 10-Q · filed 2025-11-06 | $1.51B derived: sum of 4 quarters · filed 2026-02-27 |
| 2024-06-30 | $355.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-08 | $797.00M 10-Q · filed 2025-08-08 | $1.34B derived: sum of 3 quarters · filed 2026-02-27 | $1.84B derived: sum of 4 quarters · filed 2026-02-27 |
| 2024-03-31 | $442.00M 10-Q · filed 2025-05-09 | $989.00M derived: sum of 2 quarters · filed 2026-02-27 | $1.48B derived: sum of 3 quarters · filed 2026-02-27 | $1.85B derived: sum of 4 quarters · filed 2026-02-27 |
| 2023-12-31 | $547.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $1.04B derived: sum of 2 quarters · filed 2026-02-27 | $1.41B derived: sum of 3 quarters · filed 2026-02-27 | $1.92B 10-K · filed 2026-02-27 |
| 2023-09-30 | $493.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-08 | $859.00M derived: sum of 2 quarters · filed 2024-11-08 | $1.37B 10-Q · filed 2024-11-08 | |
| 2023-06-30 | $366.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-09 | $875.00M 10-Q · filed 2024-08-09 | ||
| 2023-03-31 | $509.00M 10-Q · filed 2024-05-10 | |||
| 2022-12-31 | $1.68B 10-K · filed 2025-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |
| GLAUKOS Corp (GKOS) | United States | $9.135B | -43.73 |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |
| HAEMONETICS CORP (HAE) | United States | $4.821B | 36.52 |
| Heartflow, Inc. (HTFL) | United States | $4.225B |